Contract Pharma reached out to ChargePoint Technology’s global product manager, Michael Avraam, to discuss the expanding HPAPI sector, and the cutting edge handling and containment technologies being used to ensure the safety of employees handling HPAPIs. He explains how the implementation of technologies like SBVs can improve containment in environments where airborne exposure is a risk, and the importance of testing and validating any new technology that is introduced to improve the process of handling HPAPIs. Michael also touches on the option of streamlining the validation process by implementing containment technology that has the capacity for continuous operational monitoring, allowing for preventative maintenance. The full article can be found here from page 8.
